Skip to main content
    N

    Nkarta Inc (NKTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.21
    +0.02 (+1.68%)

    Market Cap: $85.23M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Nkarta Inc (NKTX) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Nkarta reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$104.08M, operating cash flow was -$88.70M and free cash flow was -$89.91M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$33.33M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $122.00M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0-100.0%N/AN/AN/A
    Dec 2019$115.00K-98.2%100.0%-19433.9%-18327.0%
    Dec 2018$6.55MN/A35.1%-5.4%-4.2%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$0$0$0$0$0$0$115.00K$6.55M
    Cost of revenue$0$0$0$0$0$0$0$4.25M
    Gross profit$0$0$0$0$0$0$115.00K$2.30M
    Research and development$90.43M$96.74M$96.77M$90.90M$63.41M$36.22M$17.22M$4.25M
    Operating income-$122.00M-$128.19M-$131.65M-$118.95M-$86.43M-$51.51M-$22.35M-$356.45K
    Net income-$104.08M-$108.79M-$117.50M-$113.84M-$86.08M-$91.36M-$21.08M-$274.50K
    EBITDA-$114.97M-$125.87MN/A-$117.61M-$81.45MN/A-$19.77M-$91.29K
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$9.03M$0$0$0$10.54M
    Gross profit$0$0$0-$2.26M$0$0$0$4.52M$0$0$0$8.29M
    Operating income-$35.78M-$43.13M-$30.88M-$30.96M-$27.29M-$27.19M-$36.56M-$30.92M-$33.79M-$30.71M-$32.76M-$31.18M
    Net income-$33.33M-$40.37M-$27.83M-$27.41M-$21.71M-$22.98M-$31.98M-$25.93M-$28.34M-$24.99M-$29.52M-$27.75M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $6.89M by $32.74M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$404.21M$501.20M$378.88M$472.94M$273.90M$337.65M$48.41M$9.61M
    Current assets$282.51M$273.34M$253.07M$360.69M$245.78M$318.83M$37.47M$8.23M
    Cash and equivalents$39.63M$27.87M$31.04M$37.49M$60.82M$96.69M$20.61M$7.87M
    Total liabilities$91.88M$93.23M$105.60M$100.73M$22.94M$16.43M$14.08M$15.00M
    Short-term debt$6.89M$6.05M$6.07M$4.25M$2.48M$1.40M$1.52MN/A
    Shareholder equity$312.32M$407.98M$273.29M$372.21M$250.97M$321.22M-$25.48M-$5.40M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$308.46M$337.64M$372.07M$404.21M$427.24M$448.31M$470.61M$501.20M$532.03M$554.09M$576.94M$378.88M
    Total liabilities$92.71M$89.91M$86.21M$91.88M$89.34M$90.64M$91.80M$93.23M$101.16M$100.90M$103.28M$105.60M
    Cash and equivalents$48.35M$24.96M$27.36M$39.63M$60.11M$53.41M$52.60M$27.87M$56.96M$120.40M$250.28M$31.04M
    Shareholder equity$215.75M$247.74M$285.86M$312.32M$337.90M$357.67M$378.81M$407.98M$430.87M$453.18M$473.65M$273.29M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$88.70M-$99.70M-$86.16M-$57.00M-$67.93M-$43.51M-$18.37M-$5.18M
    Capital expenditures$1.21M$4.41M$28.15M$47.11M$5.03M$7.51M$1.93M$757.88K
    Free cash flow-$89.91M-$104.11M-$114.31M-$104.11M-$72.95M-$51.02M-$20.30M-$5.94M
    Investing cash flow$100.32M-$129.56M$79.02M-$184.69M$32.53M-$210.08M-$18.30M-$757.88K
    Financing cash flow$141.00K$226.08M$691.00K$219.01M$1.20M$329.82M$49.58M$87.49K
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$25.84M-$24.22M-$28.20M-$21.65M-$18.69M-$18.75M-$29.61M-$24.75M-$24.55M-$21.89M-$28.51M-$23.35M
    Capital expenditures$1.25M$183.00K$413.00K$560.00K$8.00K$138.00K$518.00K$1.10M$777.00K$2.35M$175.00K$6.81M
    Free cash flow-$27.08M-$24.41M-$28.61M-$22.21M-$18.70M-$18.89M-$30.13M-$25.85M-$25.32M-$24.25M-$28.68M-$30.16M
    Last 12 quarters

    Frequently Asked Questions About NKTX

    What is Nkarta's annual revenue?

    Nkarta reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Nkarta profitable?

    No. Nkarta reported net income of -$104.08M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does NKTX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$88.70M minus capital expenditures of $1.21M produced free cash flow of -$89.91M.

    How much debt does Nkarta have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $6.89M and cash and equivalents of $39.63M.